Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FSCZQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,417
Award facts
- Contract value 100% obligated
- $33,416.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $33,416.58. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the supply of a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience supplying specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The Dupixent order under this delivery order supports the Defense Health Agency's pharmaceutical supply chain requirements, with the product intended for distribution through the DLA Medical Supply Chain to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FSCZQ?
SPE2DB25FSCZQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FSCZQ worth?
The government has obligated $33,417 on SPE2DB25FSCZQ.
Is contract SPE2DB25FSCZQ an order under another contract?
Yes. SPE2DB25FSCZQ is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSCZQ competed?
The extent of competition for SPE2DB25FSCZQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award